Wiliam W. Greenfield, MD

Associate Member

Research Program:

Cancer Prevention and Population Sciences

Faculty Rank:

Associate Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Obstetrics & Gynecology

Contact Information

NIH/Nat. Cancer Institute – 2R01CA143130
“Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal”
Co-Investigator
07/01/21 – 06/30/26

Shibata T, Nakagawa M, Coleman HN, [et al., including Greenfield WW]. Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota. PloS one. 2021 16(8):e0237556. PMID: 34460815. PMCID: PMC8404996.
Ravilla R, Coleman HN, Chow CE, [et al., including Greenfield WW]. Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion. Integrative cancer therapies. 2019 18:1534735419893063. PMID: 31833799. PMCID: PMC6913049.
Coleman HN, Greenfield WW, Stratton SL, [et al.]. Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination. Cancer immunology, immunotherapy : CII. 2016 65(5):563-73. PMID: 26980480. PMCID: PMC4841729.
Greenfield WW, Stratton SL, Myrick RS, [et al.]. A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. Oncoimmunology. 2015 4(10):e1031439. PMID: 26451301. PMCID: PMC4590015.